Global Plant-based Biologics Market

Plant-based Biologics Comprehensive Study by Type (Monoclonal Antibodies, Alpha Interferon, Glucocerebrosidase, Vaccines, Others), Source (Carrot, Tobacco, Duckweed, Rice, Moss, Alfalfa, Others), Plant Parts (Leaf-based, Seeds-based, Fruits-based, Tubers-based, Other) Players and Region - Global Market Outlook to 2028

Plant-based Biologics Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 3.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Plant-based Biologics Market Scope
Plant-based biologics can be defined as a Schedule D (biologic) drug produced using plant molecular farming. It is the outcome of an advanced application of biotechnology on plants that enables them to produce therapeutic protein. Plant-based biologics is considered a perfect substitute for traditional techniques that uses microbial fermentation or animal cell culture. This technology is well-equipped in providing patients with greater and immediate access to treatments and is foreseen to expand its uses in the upcoming years.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledFraunhofer IME (Germany), PlantForm (Canada), Mapp Biopharmaceutical (United States), Kentucky BioProcessing, Inc. (United States), Icon Genetics GmbH (Germany), Medicago, Inc. (Canada), iBio Inc. (United States), Greenovation Biotech GmbH (Germany) and Ventria Bioscience Inc. (United States)
CAGR3.1%


There are many large, small, and medium-sized companies in the plant-based biologics market. Market participants are primarily interested in technological advancements and alternative business strategies such as strategic partnerships; this is also a key factor in the global plant-based biologics market. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Plant-based Biologics market throughout the predicted period.

Fraunhofer IME (Germany), PlantForm (Canada), Mapp Biopharmaceutical (United States), Kentucky BioProcessing, Inc. (United States), Icon Genetics GmbH (Germany), Medicago, Inc. (Canada), iBio Inc. (United States), Greenovation Biotech GmbH (Germany) and Ventria Bioscience Inc. (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Plant-based Biologics market by Type and Region with country level break-up.

On the basis of geography, the market of Plant-based Biologics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
In September 2020, Boehringer Ingelheim and the Fraunhofer Institute for Molecular Biology and Applied Ecology announced a new collaboration to develop novel, microbial-based natural products for next-generation animal health products that combat parasitic diseases. The research will make use of Fraunhofer's well-characterized microbial strain collection, which was primarily isolated from invertebrate-associated environments.
In January 2022, Ventria Bioscience announced the launch of its new business unit, CuraVive. The new subsidiary is focused on leading the innovation in plant-based functional food ingredients.
One of the major factors that are expected to restrain the growth of the plant-based biologics market over the period is the stringent regulatory guidelines for the production of plant-based biologics. Concerns about contamination and environmental risks are also expected to stymie market growth. ProdiGene, Inc. Texas, a U.S.-based company, began large-scale production of transgenic maize that produces trypsin. However, the USDA discovered that plant remnants from a previous ProdiGene trial had contaminated a nearby conventional field.

Influencing Trend:
Technological innovations related to the Production of Plant-Derived Biologics Drugs

Market Growth Drivers:
Increase in the Number of Chronic Diseases and Consequent Demand for Biologics, Advancements in Plant Biotechnology Area and Robust pipeline of plant-based biologics

Challenges:
Strict Government Regulation and Stringent regulatory approval process, and potential risks

Restraints:
High Cost for Research and Development

Opportunities:
Low Cost of Manufacturing for the Production of Plant-based Biologics and Used as Biocontrol Agents of Foodborne Pathogens

Key Target Audience
Research and Development Institutes, Potential Investors, Regulatory Bodies, National Laboratories, Industry Associations and Others

Report Objectives / Segmentation Covered

By Type
  • Monoclonal Antibodies
  • Alpha Interferon
  • Glucocerebrosidase
  • Vaccines
  • Others
By Source
  • Carrot
  • Tobacco
  • Duckweed
  • Rice
  • Moss
  • Alfalfa
  • Others

By Plant Parts
  • Leaf-based
  • Seeds-based
  • Fruits-based
  • Tubers-based
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Number of Chronic Diseases and Consequent Demand for Biologics
      • 3.2.2. Advancements in Plant Biotechnology Area
      • 3.2.3. Robust pipeline of plant-based biologics
    • 3.3. Market Challenges
      • 3.3.1. Strict Government Regulation
      • 3.3.2. Stringent regulatory approval process, and potential risks
    • 3.4. Market Trends
      • 3.4.1. Technological innovations related to the Production of Plant-Derived Biologics Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Plant-based Biologics, by Type, Source , Plant Parts and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Plant-based Biologics (Value)
      • 5.2.1. Global Plant-based Biologics by: Type (Value)
        • 5.2.1.1. Monoclonal Antibodies
        • 5.2.1.2. Alpha Interferon
        • 5.2.1.3. Glucocerebrosidase
        • 5.2.1.4. Vaccines
        • 5.2.1.5. Others
      • 5.2.2. Global Plant-based Biologics by: Plant Parts (Value)
        • 5.2.2.1. Leaf-based
        • 5.2.2.2. Seeds-based
        • 5.2.2.3. Fruits-based
        • 5.2.2.4. Tubers-based
        • 5.2.2.5. Other
      • 5.2.3. Global Plant-based Biologics Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Plant-based Biologics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Fraunhofer IME (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. PlantForm (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Mapp Biopharmaceutical (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Kentucky BioProcessing, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Icon Genetics GmbH (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medicago, Inc. (Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. IBio Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Greenovation Biotech GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Ventria Bioscience Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Plant-based Biologics Sale, by Type, Source , Plant Parts and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Plant-based Biologics (Value)
      • 7.2.1. Global Plant-based Biologics by: Type (Value)
        • 7.2.1.1. Monoclonal Antibodies
        • 7.2.1.2. Alpha Interferon
        • 7.2.1.3. Glucocerebrosidase
        • 7.2.1.4. Vaccines
        • 7.2.1.5. Others
      • 7.2.2. Global Plant-based Biologics by: Plant Parts (Value)
        • 7.2.2.1. Leaf-based
        • 7.2.2.2. Seeds-based
        • 7.2.2.3. Fruits-based
        • 7.2.2.4. Tubers-based
        • 7.2.2.5. Other
      • 7.2.3. Global Plant-based Biologics Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Plant-based Biologics: by Type(USD Million)
  • Table 2. Plant-based Biologics Monoclonal Antibodies , by Region USD Million (2017-2022)
  • Table 3. Plant-based Biologics Alpha Interferon , by Region USD Million (2017-2022)
  • Table 4. Plant-based Biologics Glucocerebrosidase , by Region USD Million (2017-2022)
  • Table 5. Plant-based Biologics Vaccines , by Region USD Million (2017-2022)
  • Table 6. Plant-based Biologics Others , by Region USD Million (2017-2022)
  • Table 7. Plant-based Biologics: by Plant Parts(USD Million)
  • Table 8. Plant-based Biologics Leaf-based , by Region USD Million (2017-2022)
  • Table 9. Plant-based Biologics Seeds-based , by Region USD Million (2017-2022)
  • Table 10. Plant-based Biologics Fruits-based , by Region USD Million (2017-2022)
  • Table 11. Plant-based Biologics Tubers-based , by Region USD Million (2017-2022)
  • Table 12. Plant-based Biologics Other , by Region USD Million (2017-2022)
  • Table 13. South America Plant-based Biologics, by Country USD Million (2017-2022)
  • Table 14. South America Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 15. South America Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 16. South America Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 17. Brazil Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 18. Brazil Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 19. Brazil Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 20. Argentina Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 21. Argentina Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 22. Argentina Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 23. Rest of South America Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 24. Rest of South America Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 25. Rest of South America Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 26. Asia Pacific Plant-based Biologics, by Country USD Million (2017-2022)
  • Table 27. Asia Pacific Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 28. Asia Pacific Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 29. Asia Pacific Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 30. China Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 31. China Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 32. China Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 33. Japan Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 34. Japan Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 35. Japan Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 36. India Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 37. India Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 38. India Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 39. South Korea Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 40. South Korea Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 41. South Korea Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 42. Taiwan Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 43. Taiwan Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 44. Taiwan Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 45. Australia Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 46. Australia Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 47. Australia Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 48. Rest of Asia-Pacific Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 49. Rest of Asia-Pacific Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 51. Europe Plant-based Biologics, by Country USD Million (2017-2022)
  • Table 52. Europe Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 53. Europe Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 54. Europe Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 55. Germany Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 56. Germany Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 57. Germany Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 58. France Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 59. France Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 60. France Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 61. Italy Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 62. Italy Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 63. Italy Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 64. United Kingdom Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 65. United Kingdom Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 66. United Kingdom Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 67. Netherlands Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 68. Netherlands Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 69. Netherlands Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 70. Rest of Europe Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 71. Rest of Europe Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 72. Rest of Europe Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 73. MEA Plant-based Biologics, by Country USD Million (2017-2022)
  • Table 74. MEA Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 75. MEA Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 76. MEA Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 77. Middle East Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 78. Middle East Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 79. Middle East Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 80. Africa Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 81. Africa Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 82. Africa Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 83. North America Plant-based Biologics, by Country USD Million (2017-2022)
  • Table 84. North America Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 85. North America Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 86. North America Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 87. United States Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 88. United States Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 89. United States Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 90. Canada Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 91. Canada Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 92. Canada Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 93. Mexico Plant-based Biologics, by Type USD Million (2017-2022)
  • Table 94. Mexico Plant-based Biologics, by Source USD Million (2017-2022)
  • Table 95. Mexico Plant-based Biologics, by Plant Parts USD Million (2017-2022)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Plant-based Biologics: by Type(USD Million)
  • Table 106. Plant-based Biologics Monoclonal Antibodies , by Region USD Million (2023-2028)
  • Table 107. Plant-based Biologics Alpha Interferon , by Region USD Million (2023-2028)
  • Table 108. Plant-based Biologics Glucocerebrosidase , by Region USD Million (2023-2028)
  • Table 109. Plant-based Biologics Vaccines , by Region USD Million (2023-2028)
  • Table 110. Plant-based Biologics Others , by Region USD Million (2023-2028)
  • Table 111. Plant-based Biologics: by Plant Parts(USD Million)
  • Table 112. Plant-based Biologics Leaf-based , by Region USD Million (2023-2028)
  • Table 113. Plant-based Biologics Seeds-based , by Region USD Million (2023-2028)
  • Table 114. Plant-based Biologics Fruits-based , by Region USD Million (2023-2028)
  • Table 115. Plant-based Biologics Tubers-based , by Region USD Million (2023-2028)
  • Table 116. Plant-based Biologics Other , by Region USD Million (2023-2028)
  • Table 117. South America Plant-based Biologics, by Country USD Million (2023-2028)
  • Table 118. South America Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 119. South America Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 120. South America Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 121. Brazil Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 122. Brazil Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 123. Brazil Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 124. Argentina Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 125. Argentina Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 126. Argentina Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 127. Rest of South America Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 128. Rest of South America Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 129. Rest of South America Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 130. Asia Pacific Plant-based Biologics, by Country USD Million (2023-2028)
  • Table 131. Asia Pacific Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 132. Asia Pacific Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 133. Asia Pacific Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 134. China Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 135. China Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 136. China Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 137. Japan Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 138. Japan Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 139. Japan Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 140. India Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 141. India Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 142. India Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 143. South Korea Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 144. South Korea Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 145. South Korea Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 146. Taiwan Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 147. Taiwan Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 148. Taiwan Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 149. Australia Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 150. Australia Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 151. Australia Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 152. Rest of Asia-Pacific Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 153. Rest of Asia-Pacific Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 154. Rest of Asia-Pacific Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 155. Europe Plant-based Biologics, by Country USD Million (2023-2028)
  • Table 156. Europe Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 157. Europe Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 158. Europe Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 159. Germany Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 160. Germany Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 161. Germany Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 162. France Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 163. France Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 164. France Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 165. Italy Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 166. Italy Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 167. Italy Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 168. United Kingdom Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 169. United Kingdom Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 170. United Kingdom Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 171. Netherlands Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 172. Netherlands Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 173. Netherlands Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 174. Rest of Europe Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 175. Rest of Europe Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 176. Rest of Europe Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 177. MEA Plant-based Biologics, by Country USD Million (2023-2028)
  • Table 178. MEA Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 179. MEA Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 180. MEA Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 181. Middle East Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 182. Middle East Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 183. Middle East Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 184. Africa Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 185. Africa Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 186. Africa Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 187. North America Plant-based Biologics, by Country USD Million (2023-2028)
  • Table 188. North America Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 189. North America Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 190. North America Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 191. United States Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 192. United States Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 193. United States Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 194. Canada Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 195. Canada Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 196. Canada Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 197. Mexico Plant-based Biologics, by Type USD Million (2023-2028)
  • Table 198. Mexico Plant-based Biologics, by Source USD Million (2023-2028)
  • Table 199. Mexico Plant-based Biologics, by Plant Parts USD Million (2023-2028)
  • Table 200. Research Programs/Design for This Report
  • Table 201. Key Data Information from Secondary Sources
  • Table 202. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Plant-based Biologics: by Type USD Million (2017-2022)
  • Figure 5. Global Plant-based Biologics: by Plant Parts USD Million (2017-2022)
  • Figure 6. South America Plant-based Biologics Share (%), by Country
  • Figure 7. Asia Pacific Plant-based Biologics Share (%), by Country
  • Figure 8. Europe Plant-based Biologics Share (%), by Country
  • Figure 9. MEA Plant-based Biologics Share (%), by Country
  • Figure 10. North America Plant-based Biologics Share (%), by Country
  • Figure 11. Global Plant-based Biologics share by Players 2022 (%)
  • Figure 12. Global Plant-based Biologics share by Players (Top 3) 2022(%)
  • Figure 13. Global Plant-based Biologics share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Fraunhofer IME (Germany) Revenue, Net Income and Gross profit
  • Figure 16. Fraunhofer IME (Germany) Revenue: by Geography 2022
  • Figure 17. PlantForm (Canada) Revenue, Net Income and Gross profit
  • Figure 18. PlantForm (Canada) Revenue: by Geography 2022
  • Figure 19. Mapp Biopharmaceutical (United States) Revenue, Net Income and Gross profit
  • Figure 20. Mapp Biopharmaceutical (United States) Revenue: by Geography 2022
  • Figure 21. Kentucky BioProcessing, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Kentucky BioProcessing, Inc. (United States) Revenue: by Geography 2022
  • Figure 23. Icon Genetics GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Icon Genetics GmbH (Germany) Revenue: by Geography 2022
  • Figure 25. Medicago, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 26. Medicago, Inc. (Canada) Revenue: by Geography 2022
  • Figure 27. IBio Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. IBio Inc. (United States) Revenue: by Geography 2022
  • Figure 29. Greenovation Biotech GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Greenovation Biotech GmbH (Germany) Revenue: by Geography 2022
  • Figure 31. Ventria Bioscience Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Ventria Bioscience Inc. (United States) Revenue: by Geography 2022
  • Figure 33. Global Plant-based Biologics: by Type USD Million (2023-2028)
  • Figure 34. Global Plant-based Biologics: by Plant Parts USD Million (2023-2028)
  • Figure 35. South America Plant-based Biologics Share (%), by Country
  • Figure 36. Asia Pacific Plant-based Biologics Share (%), by Country
  • Figure 37. Europe Plant-based Biologics Share (%), by Country
  • Figure 38. MEA Plant-based Biologics Share (%), by Country
  • Figure 39. North America Plant-based Biologics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Fraunhofer IME (Germany)
  • PlantForm (Canada)
  • Mapp Biopharmaceutical (United States)
  • Kentucky BioProcessing, Inc. (United States)
  • Icon Genetics GmbH (Germany)
  • Medicago, Inc. (Canada)
  • iBio Inc. (United States)
  • Greenovation Biotech GmbH (Germany)
  • Ventria Bioscience Inc. (United States)
Select User Access Type

Key Highlights of Report


Oct 2023 170 Pages 91 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Plant-based Biologics Market Quantitative research analysis
Global Plant-based Biologics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Plant-based Biologics Market are by type [Monoclonal Antibodies, Alpha Interferon, Glucocerebrosidase, Vaccines and Others], by end use application [].
The Plant-based Biologics Market is gaining popularity and expected to see strong valuation by 2028.
  • Increase in the Number of Chronic Diseases and Consequent Demand for Biologics
  • Advancements in Plant Biotechnology Area
  • Robust pipeline of plant-based biologics

Know More About Global Plant-based Biologics Market Report?

Have a Query? Click Here

Other Related Reports

Infectious Vaccines Comprehensive Study by Type (Preventive Vaccine, Therapeutic Vaccine), Application (Hospitals, Clinics), Disease Type (Hepatitis A, Chickenpox, Polio, Mumps, Measles, Influenza (f...
$ 3650
Blood Plasma Fractionators Comprehensive Study by Type (Membrane Plasma Plasma Fractionator, Non-Membrane Plasma Fractionator), Application (Neurology, Immunology, Hematology, Critical care, Pulmonol...
$ 3450
Medical Membrane Comprehensive Study by Application (Pharmaceutical Filtration, Hemodialysis, Drug Delivery, IV infusion & sterile filtration, Bio-artificial processes, Others), Material (Polysulfon...
$ 3750
Smart Pills Drug Delivery Comprehensive Study by Application (Hospitals, Medical Research Center, Pharmaceutical Factory, Others), Formulations (Conventional Drug Delivery Formulations, Novel Drug De...
$ 3350
Immunochemistry Comprehensive Study by Type (Antibodies (Primary Antibodies and Secondary Antibodies), Equipment (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners...
$ 3750
Biological Wastewater Treatment Comprehensive Study by End-users (Municipal, Industrial (Pulp & Paper, Meat & Poultry, Chemicals, Pharmaceuticals, Others)), Process (Aerobic, Anaerobic) Players and R...
$ 3500